286 related articles for article (PubMed ID: 3987135)
21. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
22. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
Roy S
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
[TBL] [Abstract][Full Text] [Related]
23. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
24. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
25. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.
Beisiegel B; Treese N; Hafner G; Meyer J; Darius H
Agents Actions Suppl; 1992; 37():183-9. PubMed ID: 1378684
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
27. Hemostatic effects of smoking and oral contraceptive use.
Fruzzetti F
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S369-74. PubMed ID: 10368523
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
29. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
Alving BM; Comp PC
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
[TBL] [Abstract][Full Text] [Related]
31. Complications and contraindications of oral contraception.
Beck WW
Clin Obstet Gynecol; 1981 Sep; 24(3):893-901. PubMed ID: 7026110
[TBL] [Abstract][Full Text] [Related]
32. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
33. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
Gjonnaess H; Fagerhol MK
Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
[TBL] [Abstract][Full Text] [Related]
34. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
35. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
36. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
37. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
38. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Daly L; Bonnar J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
[TBL] [Abstract][Full Text] [Related]
40. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
